|
Volumn 8, Issue 9, 2002, Pages 2766-2774
|
Increased uptake of the apoptosis-imaging agent99mTc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
LIPOCORTIN 5;
RHENIUM TECHNETIUM TC 99M;
ADULT;
AGED;
APOPTOSIS;
ARTICLE;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG SAFETY;
DRUG TUMOR LEVEL;
FEMALE;
FOLLOW UP;
HODGKIN DISEASE;
HUMAN;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
LUNG SMALL CELL CANCER;
LYMPHOMA;
MALE;
NONHODGKIN LYMPHOMA;
PHASE 1 CLINICAL TRIAL;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SCINTIGRAPHY;
ANNEXIN A5;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SMALL CELL;
FEMALE;
FLUORODEOXYGLUCOSE F18;
FOLLOW-UP STUDIES;
HUMANS;
IMAGE INTERPRETATION, COMPUTER-ASSISTED;
LIFE TABLES;
LUNG NEOPLASMS;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
ORGANOTECHNETIUM COMPOUNDS;
RADIOPHARMACEUTICALS;
REPRODUCIBILITY OF RESULTS;
SURVIVAL ANALYSIS;
TIME FACTORS;
TOMOGRAPHY, EMISSION-COMPUTED;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 0036717347
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (299)
|
References (38)
|